DNA鑑定|一生の悩みを2日で解決|国内自社ラボDNA鑑定

【Doctor's Explanation】What is Prader-Willi Syndrome?

Introduction

Introduction

To all expectant mothers considering prenatal testing.
We understand that you are concerned about your baby's health.

In this article, we will explain Prader-Willi Syndrome (PWS), one of the genetic disorders you should know about during pregnancy, in an easy-to-understand manner.

Basic Knowledge

Basic Knowledge

PWS is a congenital genetic disorder first reported in 1956 as a syndrome presenting with endocrine abnormalities such as obesity, diabetes, short stature, and hypogonadism, as well as neurological abnormalities such as developmental delay, hypotonia, unique personality disorders, and behavioral abnormalities.
It is now known to occur with a frequency of approximately 1 in 15,000 births.*1
The onset mechanisms are as follows:*1

  • ■ "Deletion type" (approx. 70%) caused by microdeletion of the 15q11-q13 region on the long arm of chromosome 15
  • ■ "Maternal uniparental disomy (UPD)" (approx. 25%) where chromosome 15 is inherited only from the mother
  • ■ "Epimutation" (approx. 2-5%) due to methylation abnormalities
  • ■ Other rare mutations (remaining less than 1%)

Recent studies suggest that the loss of function of the "SNORD116" gene in the imprinting region of chromosome 15 (where only the father-derived gene is active) is highly likely to be an extremely important factor in the onset of PWS.*4

The vast majority of cases are not hereditary, and are thought to occur randomly after fertilization.*1

Symptoms and Features

Symptoms and Features

◇ Changes in Symptoms by Age

A characteristic feature of PWS symptoms is that they change with age, and there are significant individual differences.*4

  • [Neonatal Period (0-2 years old)] Feeding difficulties due to hypotonia are observed in almost all cases, and tube feeding is often required.*5
    In addition, hypopigmentation may cause the hair to appear light/blonde-like, and undescended testes or male genital hypoplasia are observed in more than 90% of boys.*3
  • [Early Childhood (2-6 years old)] Although feeding difficulties improve, overall developmental delay is observed. In motor development, delays occur, such as sitting up at 12 months and starting to walk at 24 months.*2
  • [School Age (6-12 years old)] Interest in food increases from around 3 to 4 years old, and it is reported that transition to hyperphagia without a feeling of fullness often occurs around an average age of 8. In addition, mild intellectual disability with an average IQ of 60-70 and characteristic behavioral symptoms emerge.*1,2
    Furthermore, children with PWS have multiple severe learning disabilities, and their academic performance tends to be poor relative to their intelligence quotient (IQ).*2
  • [Adolescence and Beyond (13 years old to Adult)] Hypogonadism leads to delayed or absent development of secondary sexual characteristics. In addition, behavioral disorders such as irritability, obsessive-compulsive symptoms, and stubbornness become more prominent with age.*2
    Furthermore, nearly 25% of adults with PWS (especially those with significant obesity) have type 2 diabetes, with an average age of onset reported to be 20 years old.*2

◇ Physical Characteristics

Facial features include a narrow bifrontal diameter, almond-shaped palpebral fissures, a narrow nasal bridge, and a thin upper lip.
These features may or may not be clearly visible at birth, but generally become gradually more prominent over time.*2

Other physical features such as scoliosis (40-80%) and strabismus (40-60%) may also be present.*2

Prognosis and Quality of Life

Prognosis and Quality of Life

With proper management, the prognosis of PWS patients improves, with a cohort study reporting an annual mortality rate of approximately 1% to 1.3%.*6
The primary causes of death in childhood are sudden death associated with respiratory failure or infections, while in adulthood, heart disease/heart failure, pulmonary thromboembolism, obesity-related complications, and gastric issues (gastric rupture, gastric necrosis) have been reported.*2

Although many patients exhibit mild intellectual disability, approximately 40% show borderline to low-normal intelligence.*2
After school age, welfare employment becomes the goal, but compared to their intellectual abilities, adaptational issues in the workplace are said to be common.*1
As they age, their personality may escalate from affectionate to persistent, stubborn, panicky, or violent, and behavioral abnormalities such as shoplifting and lying may stand out, making social adaptation difficult.*3

Treatment and Care

Treatment and Care
  • • Dietary Therapy:
    Positioned as the most crucial basic treatment.
    Caloric restriction aiming at approximately 10 kcal per centimeter of height and balanced nutritional management are required.*3,4
  • • Exercise Therapy:
    Plays an important role in weight maintenance, with swimming particularly recommended, and is effective for improving muscle strength and body composition.*3
  • • Growth Hormone Replacement Therapy:
    Highly effective for improving height and body composition, increasing muscle mass, and reducing body fat. Early initiation starting in infancy is recommended.*4
  • • Sex Hormone Replacement Therapy:
    Conducted as a treatment for hypogonadism, with expected benefits in improving bone density and providing mental health support.*3
  • • Psychotropic Medications:
    For managing behavioral and psychiatric symptoms, SSRIs (Selective Serotonin Reuptake Inhibitors) and behavioral therapy are utilized.*2,3
  • • Insulin Treatment:
    For type 2 diabetes, dietary and exercise therapies are the foundation, with medications such as metformin, GLP-1 receptor agonists, or SGLT2 inhibitors used as needed.
    Depending on the case, pharmacological therapy including insulin may be considered.4

Summary

PWS is a genetic disorder caused by abnormalities in chromosome 15.
In the neonatal period, muscle tone is weak, and a lack of strength is noticeable, but as they grow, overeating, obesity, and characteristic behavioral features begin to appear.
Thus, symptoms changing according to age is a major characteristic.

Today, early detection and proper management can significantly improve patients' quality of life.
At the core of treatment and support are medical interventions such as dietary therapy, exercise therapy, and hormone therapy. Even more crucial is a continuous support system that includes the family.

Thanks to these medical advances and comprehensive support, many patients are now able to lead stable lives.

seeDNA's Reassuring Support

seeDNA is a reliable and trusted DNA testing and genetic analysis specialist, holding both the international quality standard ISO9001 and the PrivacyMark for personal information protection.
If you are concerned about your unborn baby's disease risk, paternity relationships, or your partner's infidelity, our genetic testing experts are here to provide supportive, professional guidance. Please feel free to contact us.

[Free Consultation with Specialist Staff]
Contact Us

If you have any questions,
please feel free to contact our toll-free number.

0120-919-097

\ Open on weekends /
Hours: Mon-Sun 9:00-18:00
(Excluding Public Holidays)

References

Author
Tasuku Hiroshige, M.D., Ph.D.

Doctor of Medicine, Specialist and Board-Certified Instructor of the Japanese Urological Association, Board-Certified Member of the Japan Society of Clinical Oncology, Board-Certified Specialist of the Japanese Society of Anti-Aging Medicine, Certified Occupational Physician of the Japan Medical Association, Board-Certified Member of the Japanese Society of Chemotherapy, Board-Certified Member of the Japanese Society for Sexually Transmitted Infections, Certificate of da Vinci System Training as a Console Surgeon, etc.
After graduating from Kagoshima University Faculty of Medicine in 2010, he has built extensive clinical experience as a urologist. In addition to his clinical practice, he actively participates in academic activities such as presentations at academic conferences, paper publications, and obtaining research grants. He holds specialist certifications across a wide range of disciplines including urology, cancer treatment, anti-aging medicine, and infectious disease management. Utilizing his wealth of medical knowledge and techniques accumulated over the years, he is dedicated to providing personalized medical care tailored to each patient.

Frequently Asked Questions

Q.What is Prader-Willi Syndrome (PWS)?

A.
Prader-Willi Syndrome (PWS) is a congenital genetic disorder caused by an abnormality in the 15q11-q13 region on the long arm of chromosome 15. It occurs with a frequency of approximately 1 in 15,000 births and is characterized by hypotonia in infancy, overeating and obesity in early childhood and beyond, mild intellectual disability, and behavioral abnormalities (1). The vast majority of cases are not hereditary and occur randomly after fertilization.

Q.What causes Prader-Willi Syndrome?

A.
The causes are mainly classified into four types: (1) paternal microdeletion of the 15q11-q13 region on chromosome 15 (approx. 70%), (2) maternal uniparental disomy (approx. 25%), (3) epimutation due to methylation abnormalities (approx. 2–5%), and (4) other rare mutations (less than 1%) (1). Recent studies suggest that the loss of function of the 'SNORD116' gene in the imprinting region is a crucial factor in the onset of the syndrome (2).

Q.How do the symptoms of Prader-Willi Syndrome change with age?

A.
Symptoms change significantly at each age stage. The neonatal period (0–2 years old) is characterized by hypotonia and feeding difficulties. In early childhood (2–6 years old), motor developmental delay becomes apparent. During school age (6–12 years old), overeating without satiety starts, and mild intellectual disability with an average IQ of 60–70 also appears. From adolescence and beyond, delayed or absent secondary sexual characteristics and behavioral disorders such as irritability and obsessive-compulsive symptoms become prominent (1)(3).

Q.What treatments are available for Prader-Willi Syndrome?

A.
There are six main treatments: (1) dietary therapy targeting approximately 10 kcal per centimeter of height, (2) exercise therapy such as swimming, (3) growth hormone replacement therapy recommended to start early in infancy, (4) sex hormone replacement therapy which is also expected to improve bone density, (5) management of behavioral and psychiatric symptoms using psychotropics such as SSRIs, and (6) insulin therapy for type 2 diabetes (2)(3).

Q.Can the risk of Prader-Willi Syndrome be determined by NIPT?

A.
Yes, NIPT (Non-Invasive Prenatal Testing) can evaluate the risk of fetal Prader-Willi Syndrome during pregnancy. seeDNA provides non-invasive testing from maternal blood under an ISO9001-certified testing system. If high risk is indicated by the test results, diagnostic testing such as amniocentesis is recommended (4).